Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) closed at $253.71 in the latest trading session, marking a +2.41% move from the prior day.
Zacks Investment Research10/15/2026Neutral
CAH
Cardinal Health IncNYSEHEALTHCAREMEDICAL DISTRIBUTION
Key Statistics
Market Cap
$58.83B
P/E Ratio
35.09
EPS
$7.24
Beta
0.50
52W High
$257.70
52W Low
$154.38
50-Day MA
$234.40
200-Day MA
$219.87
Dividend Yield
0.81%
Profit Margin
0.67%
Forward P/E
17.70
PEG Ratio
1.11
About Cardinal Health Inc
Cardinal Health, Inc. is an American multinational health care services company.
Fundamentals
| Revenue (TTM) | $254.25B |
| Gross Profit (TTM) | $9.77B |
| EBITDA | $4.24B |
| Operating Margin | 1.33% |
| Return on Equity | 0.00% |
| Return on Assets | 3.72% |
| Revenue/Share (TTM) | $1077.32 |
| Book Value | $-12.37 |
| Price-to-Book | 16.07 |
| Price-to-Sales (TTM) | 0.23 |
| EV/Revenue | 0.217 |
| EV/EBITDA | 15.89 |
| Quarterly Earnings Growth (YoY) | 68.80% |
| Quarterly Revenue Growth (YoY) | 5.80% |
| Shares Outstanding | $231.56M |
| Float | $232.04M |
| % Insiders | 0.28% |
| % Institutions | 91.49% |
Historical Volatility
HV 10-Day
23.05%
HV 20-Day
24.12%
HV 30-Day
24.77%
HV 60-Day
23.65%
HV Rank
54.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($271.47 target)
3
Strong Buy11
Buy3
HoldLatest News
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.
Zacks Investment Research10/15/2026Positive
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research10/13/2026Positive
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research10/13/2026Positive
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.
Zacks Investment Research10/13/2026Negative
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.
Zacks Investment Research10/6/2026Positive
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know
Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.
Zacks Investment Research10/5/2026Positive
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
Zacks Investment Research10/1/2026Positive
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services. "We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.
PRNewsWire10/1/2026Neutral
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
PRNewsWire10/1/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CAH and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 10/17/2026